Close

FibroGen (FGEN) Misses Q4 EPS by 79c

February 28, 2022 4:24 PM EST

FibroGen (NASDAQ: FGEN) reported Q4 EPS of ($1.45), $0.79 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $47.65 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings